Strides Pharma Science’s formulations facility in Bangalore has underwent a US Food and Drug Administration (USFDA) inspection that ended on May 24, 2019. The inspection was completed successfully with a Voluntary Action Indicated (VAI) classification.
The flagship facility in Bangalore is the largest manufacturing facility for the company with capabilities to produce finished dosage formulation products across multiple dosage formats including tablet, capsules, ointments, creams and liquids. The facility services the key regulated markets of the US, Europe, and Australia.
Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.
